SCHOTT Pharma, a pioneer in drug containment solutions and delivery systems, reaffirms its commitment to science-based climate action following the validation of SCHOTT Group’s updated climate targets by the Science Based Targets initiative (SBTi). The company will continue to contribute to achieving these targets as part of its sustainability strategy. “While our commitment to climate action remains unchanged, the updated Scope 3 emissions target enables us to prioritize actions in a more impact-oriented way and focus on the emission reductions that matter most across our value chain,” said Reinhard Mayer,…
Read MoreSCHOTT Pharma advances climate action with updated science-based climate targets
